Terms: = Thyroid cancer AND SLC34A2, ENSG00000157765, O95436, NPTIIb, NAPI-IIb, NAPI-3B, FLJ90534, 10568
9 results:
1. Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability.
Hong S; Xie Y; Cheng Z; Li J; He W; Guo Z; Zhang Q; Peng S; He M; Yu S; Xu L; Liu R; Xu T; Zhang Y; Li Y; Wang J; Lv W; Yu J; Xiao H
Oncogene; 2022 Nov; 41(47):5121-5132. PubMed ID: 36253446
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 "slc34a2" in Papillary thyroid Carcinoma: An Immunohistochemical Study.
Hakim SA; Abd El Atti RM; Faheim RM; Abou Gabal HH
Anal Cell Pathol (Amst); 2021; 2021():3198555. PubMed ID: 34336552
[TBL] [Abstract] [Full Text] [Related]
3. Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate.
Wu D; Hu S; Hou Y; He Y; Liu S
BMC Cancer; 2020 Mar; 20(1):199. PubMed ID: 32164602
[TBL] [Abstract] [Full Text] [Related]
4. slc34a2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.
He J; Zhou M; Li X; Gu S; Cao Y; Xing T; Chen W; Chu C; Gu F; Zhou J; Jin Y; Ma J; Ma D; Zou Q
Oncogene; 2020 Mar; 39(13):2658-2675. PubMed ID: 32005974
[TBL] [Abstract] [Full Text] [Related]
5. Solute carrier family 34 member 2 overexpression contributes to tumor growth and poor patient survival in colorectal cancer.
Liu L; Yang Y; Zhou X; Yan X; Wu Z
Biomed Pharmacother; 2018 Mar; 99():645-654. PubMed ID: 29653487
[TBL] [Abstract] [Full Text] [Related]
6. Preclinical Development of an Anti-NaPi2b (slc34a2) Antibody-Drug Conjugate as a Therapeutic for Non-Small Cell Lung and Ovarian cancers.
Lin K; Rubinfeld B; Zhang C; Firestein R; Harstad E; Roth L; Tsai SP; Schutten M; Xu K; Hristopoulos M; Polakis P
Clin Cancer Res; 2015 Nov; 21(22):5139-50. PubMed ID: 26156394
[TBL] [Abstract] [Full Text] [Related]
7. Microarray analysis of papillary thyroid cancers in Korean.
Kim HS; Kim DH; Kim JY; Jeoung NH; Lee IK; Bong JG; Jung ED
Korean J Intern Med; 2010 Dec; 25(4):399-407. PubMed ID: 21179278
[TBL] [Abstract] [Full Text] [Related]
8. [Expression of selected genes involved in transport of ions in papillary thyroid carcinoma].
Gałeza-Kulik M; Zebracka J; Szpak-Ulczok S; Czarniecka AK; Kukulska A; Gubała E; Stojcev Z; Wiench M
Endokrynol Pol; 2006; 57 Suppl A():26-31. PubMed ID: 17091453
[TBL] [Abstract] [Full Text] [Related]
9. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications.
Jarzab B; Wiench M; Fujarewicz K; Simek K; Jarzab M; Oczko-Wojciechowska M; Wloch J; Czarniecka A; Chmielik E; Lange D; Pawlaczek A; Szpak S; Gubala E; Swierniak A
Cancer Res; 2005 Feb; 65(4):1587-97. PubMed ID: 15735049
[TBL] [Abstract] [Full Text] [Related]
